ERBB2 and breast cancer: Similarly, the stratification of breast cancer by specific characteristics should be further considered, particularly the individual metabolism, genetics, receptor status (oestrogen receptor, progesterone receptor, human epidermal growth factor receptor-2), substantial decline of ovarian hormones after menopause and other molecular classifications.